ConductScience.org, home

Paper35590010

Improved recovery after uro-oncology surgery: the critical role of pre- and re-habilitation.

Kassouf W and 1 other. World J Urol, 2022. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Improved recovery after uro-oncology surgery: the critical role of pre- and re-habilitation. Papers, record 35590010. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35590010

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Improved recovery after uro-oncology surgery: the critical role of pre- and re-habilitation.
PubMed
Journal
World J Urol
PubMed
Year
2022
PubMed
Publication types
Editorial, Comment
PubMed
Citations, by iCite
0
iCite
Relative citation ratio, by iCite
0
iCite
Revised in PubMed
2026-10-10
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kassouf WWassim
2Ploussard GGuillaume

Source PubMed

Download CSV of authors

Topics2

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Medical OncologyMajor topic
Humans

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment on33128596Role of prehabilitation following major uro-oncologic surgery: a narrative review.https://conductscience.org/library/papers/33128596

Source PubMed

Download CSV of comments and corrections

References6

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135157103Safety and feasibility of same-day discharge laparoscopic radical prostatectomy: a systematic review.World J Urol2022https://conductscience.org/library/papers/35157103PubMed
232065277Same-day discharge surgery for robot-assisted radical prostatectomy in the era of ERAS and prehabilitation pathways: a contemporary, comparative, feasibility study.World J Urol2022https://conductscience.org/library/papers/32065277PubMed
332556676Tips and tricks in achieving zero peri-operative opioid used in onco-urologic surgery.World J Urol2022https://conductscience.org/library/papers/32556676PubMed
432648071Critical analysis of quality of life and cost-effectiveness of enhanced recovery after surgery (ERAS) for patient's undergoing urologic oncology surgery: a systematic review.World J Urol2022https://conductscience.org/library/papers/32648071PubMed
532514670Day-case robotic-assisted partial nephrectomy: feasibility and preliminary results of a prospective evaluation (UroCCR-25 AMBU-REIN study).World J Urol2022https://conductscience.org/library/papers/32514670PubMed
633128596Role of prehabilitation following major uro-oncologic surgery: a narrative review.World J Urol2022https://conductscience.org/library/papers/33128596PubMed

Download CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35590010

GET https://conductscience.org/api/papers/v1/35590010/authors